The effect of Ca2+ on the pharmacological specificity of [3H]glutamate binding sites in rat hippocampus

Gangliosides modulate glutamate receptor binding in rat brain synaptic plasma membranes

The influence of gangliosides on the binding of L-[3H]glutamate (Glu) to its receptor(s) on isolated rat brain synaptic plasma membranes was investigated in two different buffer systems using an in vitro filter binding assay. It was found that the tested pure monosialogangliosides GM1 and GM2 as well as the polysialogangliosides GT1b and GD1a enhanced binding by up to about 100%, but only in the presence of 5 mM calcium. The binding site involved was sensitive to quisqualate but insensitive to N-methyl-D-aspartate and kainate. GM1 did exert its stimulating effect by increasing the number of binding sites on the membranes whereas the receptor's affinity for L-Glu was unchanged. Regional differences in rat brain were found: while the hippocampus and cortex exhibited significant Ca/GM1-induced stimulation of Glu binding, the cerebellum was unaffected. Our results suggest modulation of at least one subtype of the Glu receptor by gangliosides.

Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors

This review summarizes studies designed to label and characterize mammalian synaptic receptors for glutamate, aspartate and related acidic amino acids using in vitro ligand binding techniques. The binding properties of the 3 major ligands employed--L-[3H]glutamate, L-[3H]aspartate and [3H]kainate--are described in terms of their kinetics, the influence of ions, pharmacology, molecular nature, localization and physiological/pharmacological function. In addition, the binding characteristics are described of some new radioligands--[3H]AMPA, L-[3H]cysteine sulphinate, L-[35S]cysteate, D-[3H]aspartate, D,L-[3H]APB, D-[3H]APV and D,L-[3H]APH. Special emphasis is placed on recent findings which allow a unification of the existing binding data, and detailed comparisons are made between binding site characteristics and the known properties of the physiological/pharmacological receptors for acidic amino acids. Through these considerations, a binding site classification is suggested which differentiates 5 different sites. Four of the binding site subtypes are proposed to correspond to the individual receptor classes identified in electrophysiological experiments; thus, A1 = NMDA receptors; A2 = quisqualate receptors; A3 = kainate receptors; A4 = L-APB receptors; the fifth site is proposed to be the recognition site for a Na+-dependent acidic amino acid membrane transport process. An evaluation of investigations designed to elucidate regulatory mechanisms at acidic amino acid binding sites is made; hypotheses such as the Ca2+-activated protease hypothesis of long-term potentiation are assessed in terms of the new binding site/receptor classification scheme, and experiments are suggested which will clarify and expand this exciting area in the future.

Binding sites for L-glutamate in the central nervous system of the rat

The regional distribution of 2-amino-4-phosphonobutyrate (APB)/chloride-insensitive L-[3H]glutamate binding sites in the rat central nervous system was compared with that of APB/chloride-sensitive and with sodium-dependent binding sites. The distribution of APB-sensitive and APB-insensitive sites was not correlated, but the latter was identical to that of the sodium-dependent sites. The pharmacological specificity of the APB-insensitive sites was not consistent with that of an N-methylaspartate-preferring receptor, and was also different from the specificity determined for the sodium-dependent sites. The APB-insensitive sites appear to be unrelated to any other previously described excitatory amino acid binding site.

Regional distribution and ionic requirement of Cl-/Ca2+-activated and Cl-/Ca2+-independent glutamate receptors in rat brain

Recent studies have shown that Cl- and Ca2+ ions increase [3H]glutamate binding to rat forebrain synaptic plasma membranes by expressing a new class of glutamate receptors. We examined the regional distribution of these two classes of glutamate binding sites and further characterized their ionic requirements. Significant differences in both Cl-/Ca2+-independent (basal) and Cl-/Ca2+-activated receptors, as well as the ratios of these two receptor classes were observed among different areas of the CNS. Cl- and Ca2+ appeared to act synergistically, with Cl-ion an absolute requirement for Ca2+ stimulation, in expressing these additional binding sites. Ca2+ alone did not affect glutamate binding.

Receptors for the excitatory amino acids in the mammalian central nervous system

On the basis largely of neuropharmacological analysis, three different receptors mediating neuronal excitation can be identified. The first is activated by quisqualate and other "flexible" molecules including L-glutamate and appears to bind its ligands in a folded configuration. The second is excited by NMDA and has a more extended conformation, the spacing between the amino and the omega-carboxylate groups being the determinant of specificity. The third type accepts kainate and appears to possess a reactive site for the unsaturated side chain which is essential to the operation of this receptor. All three classes appear to be implicated in synaptic events [although some kainate receptors at least are certainly extra-synaptic (Watkins et al., 1981)] and each appears to activate different ionophores in neuronal membranes. Of the endogenous amino acids which may function as synaptic transmitters, L-glutamate and L-cysteate seem to react preferentially with quisqualate receptors (McLennan and Lodge, 1979), while L-aspartate is more of a mixed agonist capable of reaction both with quisqualate and with the NMDA types. Whether folate has a physiological role involving kainate receptors is unknown; and the same is true of any action possessed by quinolinate. The fact that there are amino acid excitants which are pharmacologically distinct from those reacting with any of the three best known receptors suggests that at least one more class of receptor may also exist, but no further information is available at the present time. Other sites with which the pharmacologically active acidic amino acids react are identifiable neurochemically in membrane preparations derived from tissues of the central nervous system. Kinetic studies and analysis of inhibition of sodium-independent binding indicate that there are sites which accept glutamate, others binding aspartate and a third which binds kainate. However, the first does not correspond completely to the quisqualate excitatory receptor, and NMDA does not react with any of the binding sites. It is difficult to conclude then that any of these binding sites can be fully identified with the excitatory receptors. Finally, there are a number of systems which in their patterns of activity again appear completely distinct, but which presumably mediate uptake of amino acids.(ABSTRACT TRUNCATED AT 400 WORDS)